期刊文献+

磁共振帕金森综合征指数在进行性核上性麻痹预后中的价值 被引量:7

Value of magnetic resonance Parkinsonism index in prognosis of progressive supranuclear palsy
下载PDF
导出
摘要 目的研究磁共振帕金森综合征指数(MRPI)对进行性核上性麻痹(PSP)预后的提示价值。方法收集临床诊断为拟诊PSP的患者17例,行MRI检查,并计算MRPI;采用PSP评定量表(PSP-RS)评分,并与MRPI值行相关分析;对患者进行电话随访,分析MRPI值与生存时间的关系。结果 17例拟诊PSP患者PSP-RS评分为(42.2±9.4),MRPI为(17.3±4.9);MRPI与PSP-RS评分呈正相关(r=0.921,P=0.004);以MRPI 15.29为界值,MRPI>15.29患者生存时间(12.6±3.6)个月,MRPI≤15.29患者生存时间(25.0±7.3)个月(P<0.05)。结论 MRPI可以提示PSP患者的预后及生存时间。 Objective To study the value of magnetic resonance Parkinsonism index(MRPI) in prognosis of progressive supranuclear palsy(PSP). Methods Seventeen PSP patients were includ- ed in this study. They underwent MRI scan and their MRPI was calculated. The patients were scored according to the progressive supranuclear palsy rating scale(PSPRS). Correlation between the scores and MRPI of the patients was analyzed. The patients were followed up by telephone. Relation between MRPI and survival time of the patients was analyzed. Results The average PSPRS score was 42.2±9.4 and the MRPI was 17.3±4.9 for the 17 PSP patients. The MRPI was positively correlated with the PSPRS scores(r=0. 921 ,P=0. 004). The average survival time of the patients with their MRPI 〉15. 29 and those with their MRPI 415. 29 was 12. 6±3. 6 months and 25.0±7.3 nosis and survival time months,respectively(P〈0.05). Conclusion MRPI can predict the prog of PSP patients.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2013年第3期273-276,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 国家自然科学基金(30700248 81271211) 江苏省基础研究计划(BK2009049) 江苏省卫生厅预防医学课题(YZ201022) 江苏省科技支撑计划(BE2011614) 南京市医药科技发展项目(YKK10113)
关键词 帕金森障碍 磁共振成像 核上麻痹 进行性 早期诊断 Parkinsonian disorders magnetic resonance imaging supranuclear palsy, progressive early diagnosis
  • 相关文献

参考文献14

  • 1Osaki Y,Ben Shlomo Y,Lees AJ,et al. The accuracy of clini cal diagnosis of progressive supranuelear palsy. Movement Disorders, 2004,19 : 181- 189.
  • 2Williams DR,de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven pro gressive supranuclear palsy: Richardson's syndrome and PSP- parkinsonism. Brain,2005,128 : 1247 -1258.
  • 3Quattrone A, Nicoletti G, Messina D, et al. MR imaging index for differentiation of progressive supranuclear palsy from Par kinson disease and the Parkinson variant of multiple system atrophy. Radiology,2008,246:214- 221.
  • 4Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele Rich- ardson-Olszewski syndrome) :report of the NIND-SPSP in ternational workshop. Neurology, 1996,47 : 1 -9.
  • 5Nicoletti G, Fera F, Condino F, et al. MR imaging of middle cerebellar peduncle width: differentiation of multiple system atrophy from Parkinson disease. Radiology, 2006,239 : 825 -830.
  • 6Williams D, Lees A. Progressive supranuelear palsy: clinico pathological concepts and diagnostic challenges. Lancet Neu rol, 2009,8 : 270-279.
  • 7Dickson DW,Ahmed Z,Algom AA,et al. Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol, 2010,23 : 394-400.
  • 8Williams DR,Lee W. Clinical features and criteria for the di agnosis of progressive supranuclear palsy. Neurodegener Dis Manag,2012,2: 125 -133.
  • 9Pastor P. Familial neurodegeneration in progressive supranu clear palsy. More frequent than expected? Neurology, 2009, 73 : 86-87.
  • 10Morelli M, Arabia G, Novellino F, et al. MRI measurements predict PSP in unclassifiable Parkinsonisms: a cohort study. Neurology, 2011,77 : 1042-1047.

同被引文献107

  • 1王丽霞,杨林.误诊为帕金森病的帕金森叠加综合征2例临床分析[J].医学信息(医学与计算机应用),2014(15):617-618. 被引量:2
  • 2侯静,陈彤,张晓红,吴卫平,王振福,郭瑞表.103例国人进行性核上性麻痹患者的临床特征[J].神经病学与神经康复学杂志,2010,7(3):135-141. 被引量:14
  • 3薛爽,魏坤,姚雪燕,乔亚男,顾卫红.进行性核上性麻痹一例脑实质超声表现[J].中华脑科疾病与康复杂志(电子版),2012,2(4):47-48. 被引量:1
  • 4Williams DR,Holton JL,Strand K. Pure akinesia with gait freezing:a third clinical phenotype of progressive supranuclear palsy[J].{H}BMC Neuroscience,2007,(15):2235-2241.
  • 5Factor SA. The clinical spectrum of freezing of gait in atypical parkinsonism[J].{H}Movement Disorders,2008,(11):1639-1640.
  • 6Imai H. Introduction and comments on the NINDS clinical criteria for the diagnosis of progressive supranuclear palsy[J].{H}No To Shinkei Brain and Nerve,1998,(4):309-316.
  • 7Levy R. Progressive supranuclear palsy:what's new[J].{H}Neurological Sciences,2011,(4):703-705.
  • 8Factor SA,Jennings DL,Molho ES. The natural history of the primary progressive freezing gait[J].{H}Archives of Neurology,2002.1778-1783.
  • 9Yener GG,Kaya GC. Improvement in Tc-99 m HMPAO brain SPECT findings during donepezil therapy in a patient with pure akinesia[J].{H}Annals of Nuclear Medicine,2005,(7):607-609.
  • 10Yamamoto M,Fujii S,Hatanaka Y. Result of long-term administration of L-threo-3,4-dihydroxyphenylserine in patients with pure akinesia as an early symptom of progressive supranuclear palsy[J].{H}Clinical Neuropharmacology,1997,(4):371-373.

引证文献7

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部